Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitogen-activated protein kinase 6 pseudogene is a non-functional genomic sequence that closely resembles the coding sequence of the MAPK6 gene, but due to accumulated mutations, it cannot produce a functional protein. Pseudogenes, including this one, can arise through gene duplication or retrotransposition events and are generally considered genomic "fossils." While most pseudogenes lack biological function, some may have regulatory roles, such as acting as decoys for microRNAs or producing non-coding RNAs that influence gene expression. However, there is no evidence that this particular pseudogene (ENSG00000275339) has any established functional or therapeutic significance[1][2]. Clarification: If your interest is in the MAPK6 protein (a member of the mitogen-activated protein kinase family involved in signal transduction and potentially implicated in cancer and other diseases), you should refer to the functional gene "Mitogen-activated protein kinase 6" (MAPK6, ENSG00000101367; not ENSG00000275339)[3][4]. The pseudogene version is not a therapeutic target and does not produce a functional protein[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-activated protein kinase 6 pseudogene.